chr19-54307742-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000432233.8(LILRA5):c.719C>T(p.Ala240Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000432233.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRA5 | NM_021250.4 | c.719C>T | p.Ala240Val | missense_variant | 6/7 | ENST00000432233.8 | NP_067073.1 | |
LILRA5 | NM_181985.4 | c.683C>T | p.Ala228Val | missense_variant | 5/6 | NP_871714.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRA5 | ENST00000432233.8 | c.719C>T | p.Ala240Val | missense_variant | 6/7 | 1 | NM_021250.4 | ENSP00000404236.4 | ||
LILRA5 | ENST00000486742.2 | c.683C>T | p.Ala228Val | missense_variant | 5/6 | 1 | ENSP00000484372.1 | |||
LILRA5 | ENST00000477720.1 | n.257C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152142Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251444Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135902
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727190
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152142Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.719C>T (p.A240V) alteration is located in exon 6 (coding exon 6) of the LILRA5 gene. This alteration results from a C to T substitution at nucleotide position 719, causing the alanine (A) at amino acid position 240 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at